Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://iolcp.com | |
Market Cap | 1,906.17 Cr. | |
Enterprise Value(EV) | 1,932.68 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 20.17 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 16.10 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.90 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 245.30 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 1.32 | Calculated using Price: 324.70 |
Dividend Yield | 1.23 | Period Ending 2022-03 |
No. of Shares Subscribed | 5.87 Cr. | 58,705,502 Shares |
FaceValue | 10 | |
Company Profile | ||
IOL Chemicals and Pharmaceuticals (IOLCP) is a leading organic chemicals manufacturers and suppliers. They are Indian manufacturer of industrial chemicals & bulk drugs for over two decades, by pursuing & implementing the highest standards of excellence in their operations, they have nurtured their capabilities by delivering consistent results and have earned the admiration of customers and stakeholders alike. |
1 Day |
|
-3.26% |
1 Week |
|
-4.32% |
1 Month |
|
-12.70% |
3 Month |
|
-10.22% |
6 Month |
|
-6.47% |
1 Year |
|
-23.93% |
2 Year |
|
-54.26% |
5 Year |
|
+319.78% |
10 Year |
|
+1225.31% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 1.85 | -34.14 | -20.72 | 2.50 | 13.70 | 69.54 | 56.93 | 43.06 | 12.50 | |
Return on Capital Employed (%) | 11.48 | -2.78 | 3.68 | 11.57 | 15.03 | 55.53 | 68.09 | 54.20 | 17.16 | |
Return on Assets (%) | 0.45 | -9.24 | -5.43 | 0.59 | 3.34 | 25.50 | 30.66 | 28.69 | 8.78 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 209 | 207 | 185 | 189 | 216 | 474 | 814 | 1,260 | 1,390 | 1,440 | |
Non Curr. Liab. | 255 | 286 | 304 | 294 | 280 | 211 | 80 | 59 | 57 | 57 | |
Curr. Liab. | 277 | 209 | 283 | 328 | 351 | 325 | 454 | 433 | 575 | 512 | |
Minority Int. | |||||||||||
Equity & Liab. | 742 | 702 | 772 | 811 | 847 | 1,010 | 1,347 | 1,752 | 2,022 | 2,009 | |
Non Curr. Assets | 460 | 418 | 416 | 396 | 416 | 458 | 499 | 600 | 882 | 1,032 | |
Curr. Assets | 281 | 283 | 357 | 415 | 431 | 552 | 848 | 1,152 | 1,141 | 977 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 742 | 702 | 772 | 811 | 847 | 1,010 | 1,347 | 1,752 | 2,022 | 2,009 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 564 | 385 | 580 | 711 | 983 | 1,685 | 1,894 | 1,967 | 2,184 | 2,234 | |
Other Income | 1 | 1 | 1 | 1 | 6 | 10 | 16 | 24 | 32 | 26 | |
Total Income | 565 | 386 | 582 | 712 | 990 | 1,696 | 1,910 | 1,991 | 2,216 | 2,260 | |
Total Expenditure | -468 | -373 | -529 | -608 | -864 | -1,276 | -1,321 | -1,375 | -1,928 | -2,044 | |
PBIDT | 97 | 13 | 53 | 103 | 126 | 420 | 590 | 616 | 288 | 216 | |
Interest | -60 | -59 | -61 | -68 | -64 | -51 | -21 | -6 | -8 | -12 | |
Depreciation | -32 | -29 | -30 | -30 | -30 | -32 | -36 | -39 | -43 | -44 | |
Taxation | -2 | 9 | -1 | -1 | -4 | -99 | -172 | -127 | -57 | -42 | |
Exceptional Items | -14 | ||||||||||
PAT | 3 | -67 | -40 | 5 | 28 | 237 | 361 | 445 | 166 | 118 | |
Adjusted EPS | 1 | -14 | -7 | 1 | 5 | 42 | 64 | 76 | 28 | 20 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 53 | 78 | -47 | 18 | 83 | 120 | 273 | 471 | 380 | 91 | |
Cash Fr. Inv. | -18 | -12 | -5 | -27 | -23 | -50 | -63 | -184 | -317 | -120 | |
Cash Fr. Finan. | -32 | -66 | 50 | 9 | -60 | -70 | -197 | -272 | -58 | -2 | |
Net Change | 3 | 1 | -2 | 0 | 1 | -1 | 13 | 15 | 4 | -31 | |
Cash & Cash Eqvt | 14 | 15 | 13 | 1 | 2 | 1 | 13 | 28 | 32 | 1 |
Fri, 20 Jan 2023
EUGMP Certification From National Institute Of Pharmacy And Nutrition Hungary With reference to the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform that National Institute of Pharmacy and Nutrition Hungary has issued Certificate of GMP Compliance of Manufacturer for Companys products. |
Fri, 20 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39 (3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 |
Mon, 09 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Please find enclosed herewith a certificate received from M/s. Alankit Assignment Limited Registrar and Share Transfer Agent of the Company in compliance with the requirements of Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st December 2022. |
Fri, 27 Jan 2023 |
|
|
|
|
|